Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Postdoctoral Researcher

Biomedical Science · China · 2025-08-21

Processing Time
612 days
Decision Date
2025-08-21
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the urgent need for cancer treatment advancements and precision medicine, which holds significant national relevance.

2 Well Positioned to Advance the Endeavor Met

The petitioner's Ph.D., 15 publications, and 540+ citations demonstrate a track record of success in cancer genomics.

3 Waiver Benefit Met

On balance, the petitioner's ongoing contributions to biomedical data science promise breakthroughs that justify waiving the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in oncology and a record of 15 peer-reviewed journal articles with over 540 citations. Evidence included publications in top-tier journals like Nature Communications and Science Advances, as well as the completion of over 20 peer reviews. The case successfully satisfied all three Dhanasar prongs following a comprehensive RFE response.

Request for Evidence (RFE)

Successfully Addressed

The RFE requested further proof of the national importance and impact of the petitioner's work. The response provided detailed citation percentiles and evidence of scholarly influence to secure approval.

RFE Targets
Substantial Merit and National ImportanceWell Positioned to Advance the EndeavorWaiver Benefit

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Government Alignment

Similar Cases

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Software Engineer

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-12-18
The petitioner proposes to advance cancer research and improve patient care by making cancer genomics data more accessible and reusable. This work involves developing scalable, interoperable data pipelines and contribution systems that allow researchers and clinicians to efficiently utilize complex genomic and clinical information.
View Case

Data Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
71 days 2025-01-04
The petitioner proposes to interrogate multimodal genomic and clinical datasets from cancer patients to uncover key associations between genetic traits, clinical features, and therapeutic responses. This work aims to enable the development of individualized cancer treatment strategies and reduce the financial and human burden of cancer in the U.S.
View Case

Biomedical Technician

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 37 days 2024-12-24
The petitioner proposes to advance cancer research by developing cutting-edge foundational models through big data analysis. This work focuses on exploring gene-gene and cell-cell interactions to improve the understanding of cellular states in cancer patients. The goal is to enable personalized treatment strategies that reduce side effects and enhance patient outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 612 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist